The present invention provides methods for treating cancer using modulators of retinoid X receptor gamma (RXRG). The ability of RXRG antagonists to disrupt the association of complexes comprising RXRG is demonstrated.
申请公布号
WO2012112623(A2)
申请公布日期
2012.08.23
申请号
WO2012US25137
申请日期
2012.02.14
申请人
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH;XU, XIAOLIANG;JHANWAR, SURESH
